A recent study shows that macrophages can be used to predict whether or not a melanoma patient will respond to chemotherapy. A study shows that humans, mice exposed to long-wavelength red light have lower rates of blood clots that cause stroke. Researchers developed an artificial intelligence algorithm that may improve the diagnosis of REM sleep behavior disorder. A new model called the Florey Dementia Index (FDI) can accurately predict the age at onset of MCI and AD. A groundbreaking study has demonstrated that artificial intelligence can enhance breast cancer detection rates by almost 20%. The CardioNerds and Dr. Mark Drazner discuss the right heart failure device placement with an elderly patient. A recent study found a connection between total serum calcium levels and developing melanoma. An electrocardiography (ECG)–based artificial intelligence risk estimator can predict the development of hypertension. People diagnosed with metastatic breast cancer have a notably increased risk of developing heart disease. Dr. Anne Morse provides a run-down of the important trends, and therapeutic innovations to occur in sleep medicine this year. Dr. Anne Marie Morse provides some gentle reminders for the health implications of over-indulgence during the holidays. A study sought to assess if a treatment combination inhibits tumor growth and metastasis in TNBC. Sacituzumab govitecan-related neutropenia can be effectively treated using G-CSF prophylaxis in patients with mTNBC. A study shows how how advancements in diagnostic tools and treatments for ATTR-CM have improved risk profiles. A recent post-hoc analysis of the ATTRibute-CM trial shows the potential for acoramidis in treating ATTR-CM. A study found an overall decline in surgical myectomy with ICD procedures since 2016. Mobile device-based 3D scanning identifies clinically relevant adolescent idiopathic scoliosis deformity. Researchers sought to assess the rate of axillary pCR in TNBC patients. Adding pembrolizumab to conventional neoadjuvant cytotoxic chemotherapy may improve survival outcomes. Researchers assessed the real-world treatment patterns and clinical outcomes of HER+ BC brain metastases.